Millennium Management LLC Sells 13,947 Shares of Integer Holdings Co. (NYSE:ITGR)

Millennium Management LLC reduced its position in Integer Holdings Co. (NYSE:ITGR - Free Report) by 74.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,908 shares of the medical equipment provider's stock after selling 13,947 shares during the period. Millennium Management LLC's holdings in Integer were worth $650,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the stock. Raymond James Financial Inc. bought a new stake in Integer during the 4th quarter valued at approximately $38,073,000. Capital Research Global Investors boosted its stake in Integer by 16.0% during the 4th quarter. Capital Research Global Investors now owns 1,410,803 shares of the medical equipment provider's stock valued at $186,960,000 after purchasing an additional 194,895 shares during the period. Artisan Partners Limited Partnership bought a new stake in Integer during the 4th quarter valued at approximately $22,775,000. Northern Trust Corp boosted its stake in Integer by 14.2% during the 4th quarter. Northern Trust Corp now owns 422,380 shares of the medical equipment provider's stock valued at $55,974,000 after purchasing an additional 52,556 shares during the period. Finally, New York State Common Retirement Fund boosted its stake in Integer by 20.9% during the 4th quarter. New York State Common Retirement Fund now owns 232,569 shares of the medical equipment provider's stock valued at $30,820,000 after purchasing an additional 40,158 shares during the period. Institutional investors and hedge funds own 99.29% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on ITGR. KeyCorp decreased their target price on Integer from $154.00 to $145.00 and set an "overweight" rating for the company in a research note on Monday, April 21st. Truist Financial set a $150.00 price objective on Integer and gave the stock a "buy" rating in a research report on Friday, April 25th. Oppenheimer downgraded Integer from an "outperform" rating to a "market perform" rating in a research report on Friday, February 21st. Citigroup upgraded Integer from a "hold" rating to a "strong-buy" rating and raised their price objective for the stock from $133.00 to $140.00 in a research report on Thursday, May 22nd. Finally, Raymond James raised their price objective on Integer from $145.00 to $150.00 and gave the stock an "outperform" rating in a research report on Friday, April 25th. Two analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, Integer presently has an average rating of "Moderate Buy" and an average price target of $145.00.

Insiders Place Their Bets

In other Integer news, CEO Joseph W. Dziedzic sold 338,975 shares of Integer stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $123.17, for a total transaction of $41,751,550.75. Following the transaction, the chief executive officer now directly owns 47,000 shares in the company, valued at approximately $5,788,990. The trade was a 87.82% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Donald J. Spence sold 14,739 shares of Integer stock in a transaction dated Wednesday, June 4th. The stock was sold at an average price of $120.38, for a total value of $1,774,280.82. Following the transaction, the director now owns 18,781 shares in the company, valued at approximately $2,260,856.78. This represents a 43.97% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 362,434 shares of company stock worth $44,577,115. Corporate insiders own 2.16% of the company's stock.

Integer Trading Down 2.0%

Shares of NYSE:ITGR traded down $2.48 during midday trading on Wednesday, hitting $120.05. The company had a trading volume of 384,756 shares, compared to its average volume of 376,894. Integer Holdings Co. has a 12 month low of $104.93 and a 12 month high of $146.36. The company has a current ratio of 2.95, a quick ratio of 2.09 and a debt-to-equity ratio of 0.62. The stock has a market cap of $4.19 billion, a price-to-earnings ratio of 35.73, a PEG ratio of 1.72 and a beta of 0.98. The firm has a fifty day simple moving average of $119.07 and a 200 day simple moving average of $127.82.

Integer (NYSE:ITGR - Get Free Report) last posted its quarterly earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.27 by $0.04. Integer had a return on equity of 11.65% and a net margin of 6.92%. The business had revenue of $437.39 million for the quarter, compared to analyst estimates of $428.51 million. During the same period last year, the company earned $1.14 EPS. The firm's revenue was up 7.3% on a year-over-year basis. On average, analysts predict that Integer Holdings Co. will post 6.01 EPS for the current year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.